Cite
N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability
MLA
Ying Ji, et al. “N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.” Cancers, vol. 14, no. 22, Nov. 2022, p. 5582. EBSCOhost, https://doi.org/10.3390/cancers14225582.
APA
Ying Ji, Qing Zhao, Wei Feng, Yue Peng, Bin Hu, & Qirui Chen. (2022). N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability. Cancers, 14(22), 5582. https://doi.org/10.3390/cancers14225582
Chicago
Ying Ji, Qing Zhao, Wei Feng, Yue Peng, Bin Hu, and Qirui Chen. 2022. “N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.” Cancers 14 (22): 5582. doi:10.3390/cancers14225582.